Most patents sell for less than their owners expect. Across tens of thousands of recorded transactions, median asking prices for a patent family land somewhere between $100,000 and $250,000, with individual patents changing hands for as little as $38,000 and as much as several million dollars. So the honest answer to how much is a patent worth is that it depends almost entirely on what the claims cover, how much time is left on the term, how large the market is, and whether the patent can survive a challenge. Getting to a specific number means picking a valuation method and pressure-testing the assumptions behind it.
What Drives the Number
Claim scope does more work than any other factor. Claims define exactly what the owner can stop others from doing. A patent covering “a method of wirelessly charging a device through any surface” blocks a market. A patent covering “a wireless charging coil with a specific copper-winding configuration” blocks one product design. The first is a different asset than the second, and priced accordingly.
Remaining term is the next lever. Utility patents run twenty years from the original filing date, not the issue date. A patent with fifteen years left has real licensing runway; one with three does not. Buyers discount as the clock runs down, because on expiration the technology becomes free for anyone to use.
Market size amplifies whatever the claims cover. The same quality patent generates far more revenue reading on a component in smartphones than in a niche industrial product, simply because hundreds of millions of units ship each year in one and a few thousand in the other. Standard-essential patents sit in a special tier: when a standards body adopts a technology and manufacturers must use it for interoperability, the owner has leverage over every participant. That leverage comes with a limit. Standard-essential patent holders are expected to license on fair, reasonable, and non-discriminatory terms, and courts have found per-patent royalties for standard-essential patents often land in fractions of a penny per unit. The dollars are real only because the volume is.
Keeping the patent alive costs money that comes out of the value. The USPTO charges maintenance fees at three points after issuance, and a missed payment lapses the patent entirely. For a large entity, current fees are $2,150 at 3.5 years, $4,040 at 7.5 years, and $8,280 at 11.5 years.1USPTO. USPTO Fee Schedule – Current Small and micro entities pay reduced rates. Miss a deadline and a six-month grace period lets you pay late with a $540 surcharge; miss that too and reinstatement starts at $2,260.2United States Patent and Trademark Office. Maintain Your Patent For a portfolio of any size, those numbers belong in the valuation.
Three Ways to Put a Dollar Figure on It
Cost Approach
The cost approach asks what it would take to recreate the invention from scratch. An analyst adds up the labor, lab work, prototyping, and legal fees spent on development, then estimates what a competitor would have to spend to get to the same result independently. The total is a floor value. This works best for early-stage patents with no revenue history, because there is no income data to model. Its weakness is that it ignores demand. A patent might have cost $2 million to develop and cover something nobody wants to buy.
Market Approach
The market approach works like a real estate comparable. Find similar patents that recently sold or were licensed, and use those prices as a benchmark. Analysts search transaction databases for patents in the same technology sector with similar claim scope and remaining life. When good comparables exist, this gives the most realistic picture of what a buyer would pay. The catch is that patent transactions are often confidential, and genuinely unique inventions may have no meaningful comparables. It performs best in well-traded areas like semiconductors and wireless communications, where deals happen often enough to establish norms.
Income Approach
The income approach is what most buyers and investors reach for on established technologies. It projects the revenue the patent will generate over its remaining life, then discounts those future cash flows back to a present value. The discount rate carries the risk: a competitor finding a workaround, the market shrinking, a validity challenge succeeding. A patent generating $500,000 a year in licensing fees with twelve years left is not worth $6 million today, because future money is worth less than money now and because things go wrong. The discount rate is where most disagreements happen. Moving from 10% to 20% can cut the final number in half.
How Validity Risk Cuts the Price
A patent is only worth something if it survives a challenge. Since 2012, anyone other than the owner can file an inter partes review petition with the Patent Trial and Appeal Board, asking the Board to cancel claims as unpatentable based on prior art.3Office of the Law Revision Counsel. 35 US Code 311 – Inter Partes Review The standard of proof is lower than in federal court. In pharmaceutical and biotech patents, historical data shows roughly a third of claims reaching a final decision are found unpatentable.
Buyers and licensees discount vulnerable patents accordingly. Strong prior art and arguably obvious claims mean a significant validity discount. A patent that has already survived an IPR is worth more, because it has been battle-tested. Sophisticated buyers build validity risk directly into the discount rate used in the income approach.
What Infringement Damages Say About Value
Litigation produces some of the clearest dollar figures in the patent world. When a court finds infringement, federal law requires damages adequate to compensate the owner, with a floor of a reasonable royalty for the infringer’s use.4Office of the Law Revision Counsel. 35 USC 284 – Damages Damages take two forms.
Lost profits apply when the owner can show they would have made the infringer’s sales themselves. That takes evidence of manufacturing capacity, demand for the patented product, and a lack of non-infringing alternatives. When the owner doesn’t compete directly or can’t prove lost sales, courts calculate a reasonable royalty: the hypothetical license fee the parties would have agreed to before infringement began. Courts weigh any established royalty the owner has charged others, the commercial relationship between the parties, the profitability of the product, and the share of profit attributable to the patent rather than to unpatented features.
For egregious infringement, the statute lets courts increase the award up to three times the amount found.4Office of the Law Revision Counsel. 35 USC 284 – Damages The Supreme Court held in 2016 that enhanced damages are reserved for willful misconduct and left to the district court’s discretion, with no rigid test required.5Justia. Halo Electronics Inc v Pulse Electronics Inc The possibility of trebling raises the enforcement value of patents with clear targets, because the threat alone can push settlements higher.
What You Can Actually Do With It
Licensing is the usual way to turn a patent into cash without giving up ownership. The holder grants permission to use the technology for royalties, structured as a per-unit fee, a percentage of revenue, or an upfront lump sum. Rates vary widely by industry. Consumer electronics and software patents commonly license in the low single digits as a percentage of revenue. Pharmaceutical patents can command much higher rates because the patent often covers the entire product rather than one component of many. Well-drafted license agreements usually include minimum annual payments so the owner receives a baseline even when the licensee underperforms.
An outright assignment transfers all ownership permanently. Federal law requires patent assignments in writing, and an unrecorded assignment is void against a later buyer or lender without notice, unless recorded at the USPTO within three months or before the later transaction occurs.6Office of the Law Revision Counsel. 35 US Code 261 – Ownership; Assignment Individual inventors who can’t commercialize or enforce a patent often take this route, trading long-term royalty potential for immediate capital.
Cross-licensing is a third path that doesn’t always involve cash. Two companies with overlapping portfolios agree to let each other use their respective technologies, avoiding mutual litigation. It is common among large technology firms, where any new product might touch hundreds of patents held by competitors. The patent’s value in a cross-license is measured in dollars saved rather than dollars received. Defensive patents still carry real economic value; it just shows up as avoided costs.
Tax Consequences That Change the Net
The IRS treats patent income differently depending on whether you license the patent or sell it. Royalty income from licensing is ordinary income, taxed at your marginal rate like wages or business profits.7Internal Revenue Service. Publication 525 – Taxable and Nontaxable Income
Selling is often more tax-efficient. If you qualify as a “holder” under the tax code and transfer all substantial rights, the sale is treated as long-term capital gain regardless of how long you actually held the patent and regardless of whether payment comes in installments tied to the buyer’s use.8Office of the Law Revision Counsel. 26 US Code 1235 – Sale or Exchange of Patents A holder is the individual inventor or someone who bought an interest from the inventor before the invention was reduced to practice, provided that buyer isn’t the inventor’s employer or a related person. Corporations don’t qualify. For individual inventors, the gap between ordinary rates and long-term capital gains rates can make an outright sale more attractive than licensing on tax grounds alone.
On the buyer’s side, a patent acquired as part of a business transaction can be amortized over fifteen years, regardless of its remaining legal life.9Office of the Law Revision Counsel. 26 USC 197 – Amortization of Goodwill and Certain Other Intangibles That schedule applies to patents acquired as Section 197 intangibles, which covers most patents purchased in connection with a business acquisition.
Before You Buy or Sell
Anyone paying real money for a patent should verify three things before signing: clear ownership, enforceable claims, and freedom from encumbrances. The USPTO maintains public assignment records showing transfers, security interests, and liens against each patent. Gaps in the chain of title are one of the most common problems surfaced during due diligence. If a previous assignment wasn’t recorded within three months, a later purchaser without notice could have superior rights.6Office of the Law Revision Counsel. 35 US Code 261 – Ownership; Assignment
Beyond ownership, confirm that maintenance fees are current, review the prosecution history for narrowing amendments that weakened the claims, and check whether anyone has filed or threatened an inter partes review. Existing license agreements affect what a buyer actually gets, because a patent sold subject to outstanding licenses comes with obligations the new owner must honor. In mergers and acquisitions, the IP audit usually includes a full inventory of patents, pending applications, license agreements, and any infringement disputes involving the target. Skipping that work is how buyers pay millions for a portfolio with fatal title defects or unenforceable claims.